alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,751–6,775 of 7,816 matching trials · page 271 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic
NCT02187796
Runs in: United States · 1 site 		NA
other		 COMPLETED 50 East Tennessee State University
OTHER		 2015-08-04
Patient Participation in Prevention of Loss of Functions
NCT01843907
Empowerment; Conversation with nurse
Runs in: Denmark · 1 site 		NA
other		 COMPLETED 300 Herlev Hospital
OTHER		 2015-07-31
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601
MK3134; Comparator: Placebo; Donepezil; MK3134 		PHASE1
symptomatic-cholinergic		 COMPLETED 32 Merck Sharp & Dohme LLC
INDUSTRY		 2015-07-30
What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?
NCT01692977
neuropsychological assessment
Runs in: France · 1 site 		NA
other		 COMPLETED 77 Central Hospital, Nancy, France
OTHER		 2015-07-30
Alzheimer's Disease, Art and Garden
NCT02208193
Cognitive and psycho-behavioral effects of an artistic dimension
Runs in: France · 1 site 		NA
other		 UNKNOWN 60 Central Hospital, Nancy, France
OTHER		 2015-07-30
Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
NCT00630500
Memantine; Placebo
Runs in: Norway; Sweden; United Kingdom · 4 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 75 Helse Stavanger HF
OTHER_GOV		 2015-07-28
Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia
NCT02350738
Period I MCET (8 wks); Washout (4 wks); Period II MCET (8 wks)
Runs in: South Korea · 1 site 		PHASE3
other		 COMPLETED 64 Ki Woong Kim
OTHER		 2015-07-28
Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)
NCT00074529
MK0677 		PHASE2
other		 COMPLETED 512 Merck Sharp & Dohme LLC
INDUSTRY		 2015-07-24
A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)
NCT01325662 		NA
other		 COMPLETED 11 Merck Sharp & Dohme LLC
INDUSTRY		 2015-07-23
Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population.
NCT01817101
Omega-3 fatty acid supplementation
Runs in: Spain · 3 sites 		NA
other		 UNKNOWN 170 Clinica Universidad de Navarra, Universidad de Navarra
OTHER		 2015-07-17
Memory and Insulin in Early Alzheimer's Disease
NCT00581867
Insulin Aspart; Placebo
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 COMPLETED 31 Jeff Burns, MD
OTHER		 2015-07-14
The Feasibility of Florbetapir Quantitation in Europe
NCT02107599
Florbetapir (18F)
Runs in: Netherlands · 1 site 		PHASE4
other		 COMPLETED 96 Avid Radiopharmaceuticals
INDUSTRY		 2015-07-09
Telesupport: Evaluation of Professionally Led Support Groups for Caregivers
NCT00259415
Caregiver support via telephone
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED — Thomas Jefferson University
OTHER		 2015-07-08
The Feasibility of Florbetapir Quantitation
NCT01946243
Florbetapir F18
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 96 Avid Radiopharmaceuticals
INDUSTRY		 2015-06-29
Reminiscence, Anxiety and Early Alzheimer's Disease
NCT02319681
Simple Reminiscence (SR); Attention Control (AC)
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Emory University
OTHER		 2015-06-26
Impact of Hospital Admission on Patients With Dementia
NCT02483065
mortality at discharge and 3-months after the admission in patients... 		NA
other		 UNKNOWN 413 Hospital Galdakao-Usansolo
OTHER_GOV		 2015-06-26
A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
NCT01978548
JNJ-54861911 10 mg; JNJ-54861911 50 mg; Placebo
Runs in: Belgium; Netherlands; Spain; Sweden · 10 sites 		PHASE1
other		 COMPLETED 45 Janssen Research & Development, LLC
INDUSTRY		 2015-06-25
Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone
NCT01119638
Escitalopram; Risperidone
Runs in: Israel · 1 site 		PHASE4
other		 COMPLETED 40 Abarbanel Mental Health Center
OTHER_GOV		 2015-06-24
Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006
NCT02008513
AFFITOPE® AD02; Placebo
Runs in: Austria; Croatia; Czechia; France; Germany; Slovakia · 27 sites 		PHASE2
other		 TERMINATED 194 Affiris AG
INDUSTRY		 2015-06-24
The Role of the Coagulation Pathway at the Synapse in Prion Diseases
NCT02480725
collect CSF (Cerebrospinal fluid) sample 		NA
other		 UNKNOWN 50 Sheba Medical Center
OTHER_GOV		 2015-06-24
CATIE-Alzheimer's Disease Trial
NCT00015548
Olanzapine; Quetiapine; Risperidone; Citalopram
Runs in: United States · 34 sites 		NA
other		 COMPLETED 450 National Institute of Mental Health (NIMH)
NIH		 2015-06-17
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
NCT01357681
(2)-epigallocatechin-3-gallate (EGCG); Placebo
Runs in: Germany · 3 sites 		PHASE2
other		 COMPLETED 54 Charite University, Berlin, Germany
OTHER		 2015-06-16
Wheelchair-bound Senior Elastic Band (WSEB) Exercise Program for the Demented Seniors
NCT02164617
Wheelchair-bound Senior Elastic Band exercise program (WSEB)
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 150 Kaohsiung Medical University
OTHER		 2015-06-16
Alzheimer's Disease Core Center
NCT01421420
Runs in: United States · 1 site 		NA
other		 UNKNOWN 900 University of Arizona
OTHER		 2015-06-12
Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial
NCT01550718
ESML-EX (Physical Activity Program); ESML-Social (Social Activity Program)
Runs in: United States · 1 site 		NA
other		 COMPLETED 152 University of Washington
OTHER		 2015-06-10

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →